•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student
other

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

2 DSK Legal PEs: $181m biggest health fundraising with Tatva & 1 more with Desai & Diwanji and R&A

Healthcare fundraising
Healthcare fundraising

DSK Legal advised India Value Fund Advisors’ (IVFA) trustee IVF Trustee Company in its Rs 1000 crore ($181m) investment in Bangalore-based Manipal Health Enterprises which was advised by Tatva Legal.

DSK Legal Mumbai partner Narendra Dingankar, manager Hemang Parekh and associate Anupam Shukla acted for IVF Trustee Company on what VC Circle reported is the largest private equity investment in an Indian healthcare company.

IVFA has $1.4bn in assets under management and has been bullish on healthcare, according to the Times of India.

Tatva Legal Bangalore partner Manav Nagaraj acted for Manipal Health Enterprises and its promoters Manipal Global Health Services and Dr Ranjan Pai. In August Mint reported on the speculated fundraising by Manipal to double its hospital bed capacity in the next three years.

DSK Legal also advised Ahmedabad-based Biotechnology company Marck Biosciences in its fundraising from Tata Capital Healthcare Fund (TCH) which was advised by Desai & Diwanji, and IFCI Venture Capital Funds which was advised by R&A Associates.

DSK Legal Mumbai partner Narendra Dingankar and senior manager Rishabh Mastaram acted for Mark Biosciences.

Desai and Diwanji Mumbai partner Vihang Virkar acted for TCH.

R&A Associates founder partner Raghu Babu Gunturu acted for IFCI Venture Capital Funds.

Photo by: Jose Goulao

Click to show 11 comments
at your own risk
(alt+c)
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.